JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 17, 2006; DOI: 10.1124/jpet.106.110080


0022-3565/06/3192-898-906$20.00
JPET 319:898-906, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.110080v1
319/2/898    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehrlich, J. R.
Right arrow Articles by Gögelein, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehrlich, J. R.
Right arrow Articles by Gögelein, H.

CARDIOVASCULAR

Properties of a Time-Dependent Potassium Current in Pig Atrium: Evidence for a Role of Kv1.5 in Repolarization

Joachim R. Ehrlich, Christin Hoche, Pierre Coutu, Christiane Metz-Weidmann, Werner Dittrich, Stefan H. Hohnloser, Stanley Nattel, and Heinz Gögelein

Division of Cardiology, J.W. Goethe-University, Frankfurt, Germany (J.R.E., C.H., S.H.H.); Research Center and Department of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada (P.C., S.N.); Genomic Sciences, Sanofi-Aventis, Frankfurt, Germany (C.M.-W., W.D.); Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada (S.N.); and Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany (H.G.)

Cardiac electrical activity is modulated by potassium currents. Pigs have been used for antiarrhythmic drug testing, but only sparse data exist regarding porcine atrial ionic electrophysiology. Here, we used electrophysiological, molecular, and pharmacological tools to characterize a prominent porcine outward K+ current (IK,PO) in atrial cardiomyocytes isolated from adult pigs. IK,PO activated rapidly (time to peak at +60 mV; 2.1 ± 0.2 ms), inactivated slowly ({tau}f = 45 ± 10; {tau}s = 215 ± 28 ms), and showed very slow recovery ({tau}f = 1.54 ± 0.73 s; {tau}s = 7.91 ± 1.78 s; n = 9; 36°C). Activation and inactivation were voltage-dependent, and current properties were consistent with predominant K+ conductance. Neurotoxins (heteropodatoxin, hongatoxin, and blood depressing substance) that block Kv4.x, Kv1.1, -1.2, -1.3, and -3.4 in a highly selective manner as well as H2O2 and tetraethylammonium, did not affect the current. Drugs with Kv1.5-blocking properties (flecainide, perhexiline, and the novel atrial-selective antiarrhythmic 2'-{2-(4-methoxyphenyl)-acetylamino-methyl}-biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide; AVE0118) inhibited IK,PO (IC50 of 132 ± 47, 17 ± 10, and 1.25 ± 0.62 µM, respectively). 4-Aminopyridine suppressed the current and accelerated its decay, reducing charge carriage with an IC50 of 39 ± 15 µM. Porcine-specific Kv channel subunit sequences were cloned to permit real-time quantitative reverse transcription-polymerase chain reaction on RNA extracted from isolated cardiomyocytes, which showed much greater abundance of Kv1.5 mRNA compared with Kv1.4, Kv4.2, and Kv4.3. Action potential recordings showed that IK,PO inhibition with 0.1 mM 4-AP delayed repolarization (e.g., action potential duration at –50 mV increased from 45 ± 9 to 69 ± 5 ms at 3 Hz; P < 0.05). In conclusion, porcine atrium displays a current that is involved in repolarization, inactivates more slowly than classic transient outward current, is associated with strong Kv1.5 expression, and shows a pharmacological profile typical of Kv1.5-dependent currents.


Received for publication June 28, 2006
Accepted August 15, 2006.

Address correspondence to: Dr. Joachim R. Ehrlich, Division of Cardiology, J.W. Goethe-University, Theodor Stern Kai 7, 60590 Frankfurt, Germany. E-mail: j.ehrlich{at}em.uni-frankfurt.de




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. R. Ehrlich, P. Biliczki, S. H. Hohnloser, and S. Nattel
Atrial-Selective Approaches for the Treatment of Atrial Fibrillation
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 787 - 792.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.